

About Step Pharma
Step Pharma is discovering and developing novel therapeutics that inhibit the enzyme CTP Synthase 1 (CTPS1).
Step Pharma was created on the basis of research on genetic immunodeficiencies led by Prof. Alain Fischer at the Imagine Institute (Paris, France) which established the essential role of CTPS1 in T- and B-cell proliferation.
Latest news
5 September 2019
Step Pharma Appoints Seasoned Drug Developer Dr. Andrew Parker as Chief Executive Officer
Paris, France, 6 September 2019 – Step Pharma, a biotech company developing novel drugs for autoimmune diseases, today…
Upcoming events
Step Pharma will be present at the following events